Sperm protein 17 is a novel biomarker for low grade serous ovarian adenocarcinoma

被引：0
|
作者：
Brunette, L. L. [1 ]
DaSilva, D. [2 ]
Mhawech-Fauceglia, P. [1 ]
Kast, W. M. [2 ]
机构：
[1] USC, LAC, Med Ctr, Los Angeles, CA USA
[2] USC, Keck Sch Med, Los Angeles, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.342
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
339
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Novel therapeutics in low-grade serous ovarian cancer
    Cobb, Lauren
    Gershenson, David
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 377 - 384
  • [2] Low-Grade Ovarian Serous Adenocarcinoma with Lymph Node Metastasis in Neck
    Chen, Shih-Lung
    Hsieh, Tsan-Yu
    Yang, Shih-Wei
    DIAGNOSTICS, 2021, 11 (10)
  • [3] FKBPL as a novel therapeutic target and prognostic biomarker in high grade serous ovarian cancer
    Annett, Stephanie
    Moore, Gillian
    Short, Amy
    Moustafa, Neermeen
    Das, Sudipto
    O'Connor, Darran
    McCrudden, Cian
    Kissenpfenning, Adrien
    Nelson, Laura
    Harley, Ian
    Arthur, Ken
    Yakkundi, Anita
    McCluggage, Glen
    Marshall, Andrea
    Furlong, Fiona
    McCarthy, Helen O.
    Cotton, Graham
    Harrison, Timothy
    McClements, Lana
    Robson, Tracy
    CANCER RESEARCH, 2018, 78 (13)
  • [4] LINE-1, A NOVEL BIOMARKER FOR HIGH-GRADE SEROUS OVARIAN CARCINOMA
    Nguyen, T. H. M.
    Upton, K. R.
    Faulkner, G. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 219 - 219
  • [5] MIIC and low grade serous ovarian cancer
    Madar, Alexandra
    Gaillard, Thomas
    Laas, Enora
    Pautier, Patricia
    Ngo, Charlotte
    Le Fre're-Belda, Marie-Aude
    Kalbacher, Elsa
    Floquet, Anne
    Berton-Rigaud, Dominique
    Lefeuvre-Plesse, Claudia
    Fabbro, Michel
    Ray-Coquard, Isabelle
    Panchbhaya, Nabilah
    Bats, Anne-Sophie
    Pujade-Lauraine, Eric
    Ferron, Gwenael
    Pomel, Christophe
    Leblanc, Eric
    Nadeau, Cedric
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A409 - A409
  • [6] Low-grade Serous Ovarian Carcinoma
    Ricciardi, Enzo
    Baert, Thais
    Ataseven, Beyhan
    Heitz, Florian
    Prader, Sonia
    Bommert, Mareike
    Schneider, Stephanie
    du Bois, Andreas
    Harter, Philipp
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2018, 78 (10) : 972 - 976
  • [7] The role of PAX2 as a potential biomarker of low-grade serous ovarian carcinoma
    Tung, C. S.
    Yeung, C.
    Mok, S. C.
    Birrer, M. J.
    Lu, K. H.
    Gershenson, D. M.
    Wong, K.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S57 - S57
  • [8] A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
    Han, Chanhee
    Bellone, Stefania
    Siegel, Eric R.
    Altwerger, Gary
    Menderes, Gulden
    Bonazzoli, Elena
    Egawa-Takata, Tomomi
    Pettinella, Francesca
    Bianchi, Anna
    Riccio, Francesco
    Zammataro, Luca
    Yadav, Ghanshyam
    Marto, Jarrod A.
    Penet, Marie-France
    Levine, Douglas A.
    Drapkin, Ronny
    Patel, Abhijit
    Litkouhi, Babak
    Ratner, Elena
    Silasi, Dan-Arin
    Huang, Gloria S.
    Azodi, Masoud
    Schwartz, Peter E.
    Santin, Alessandro D.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (03) : 585 - 591
  • [9] Ovarian Serous Tumors of Low Malignant Potential with Nodal Low Grade Serous Carcinoma
    Djordjevic, B.
    Malpica, A.
    MODERN PATHOLOGY, 2011, 24 : 243A - 243A
  • [10] MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
    Li, Hai Ming
    Qiang, Jin Wei
    Xia, Gan Lin
    Zhao, Shu Hui
    Ma, Feng Hua
    Cai, Song Qi
    Feng, Feng
    Fu, Ai Yan
    JOURNAL OF OVARIAN RESEARCH, 2015, 8
12345